Drugs Made In America Acquisition (DMII) Accumulated Expenses (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Accumulated Expenses of $88343.0 for Q4 2025, up 1786.46% year-over-year from $4683.0 in Q4 2024, and up 1411.95% quarter-over-quarter from $5843.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Accumulated Expenses (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Accumulated Expenses data on file, last reported at $88343.0 in Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $88343.0, up 1786.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $88343.0 (up 1786.46% YoY), and the FY2025 annual result was $88343.0, up 1786.46% from the prior year.
- Accumulated Expenses advanced to $88343.0 in Q4 2025 per DMII's latest filing, from $5843.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $88343.0 in Q4 2025 and troughed at $4683.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,343.00 |
| Sep 30, 2025 | 5,843.00 |
| Dec 31, 2024 | 4,683.00 |